Actualités Communiqués de presse
CONTEXT: Latest update (8 April 2021) from LEEM describing the role of the QP PV | Must read! IMPACT: Medium READ TIME: 1 min Quality Level Mean [1 – 10]: Continue Reading
New Roche data at 2021 AAN highlight impact and breadth of expanding neuroscience portfolio – Yahoo Finance
CONTEXT: A comprehensive summary of multiple studies | Low key press release with potentially big impact in the real world IMPACT: Medium READ TIME: 3 mins Quality Level Mean [1 Continue Reading
Complications of cardiovascular events | IDR – Dove Medical Press
CONTEXT: When the world falls apart, we still (thankfully) have studies focusing on the stuff (viruses) that impact us when we aren’t focusing on COVID | This is a retrospective Continue Reading
Peginterferon beta-1a was associated with high adherence and satisfaction in patients with multiple sclerosis in a German real-world study – DocWire News
CONTEXT: Prospective observational study in releasing remitting multiple sclerosis (RRMS) with a relatively old treatment showing a fairly content and stable patient population in Germany | Study conducted between 2015 Continue Reading
Cerner Finalizes Acquisition of Kantar HealthPairing data and research expertise to revolutionize the discovery, development and commercialization of life sciences innovations – BioSpace
CONTEXT: Commercial announcement of a significant acquisition in the RWD space | Is this the biggest deal we will see this year or is there more to come? IMPACT: Medium Continue Reading
ForeseeHome AMD home monitoring real-world data analysis demonstrates substantial benefit for patients’ vision – GlobeNewswire
CONTEXT: This retrospective analysis of an at-home monitoring system gives hope for suffers of age-related macular degeneration (AMD) | The large sale analysis of US patients showed the system could Continue Reading
Variations in Utilization and Sequencing Observed in Biomarker Testing Among Patients With Advanced NSCLC – Cancer Network
CONTEXT: Relatively small scale RWE study (102 patients) on the variation in biomarker testing in NSCLC patients in the Netherlands. IMPACT: Low READ TIME: 1 min Quality Level Mean [1 Continue Reading
New Real-World Observational Analysis of UPTRAVI® (selexipag) Underscores the Importance of Risk Assessment for Treating Pulmonary Arterial Hypertension (PAH) Patients – PRNewswire
CONTEXT: Publication from the analysis of the first 500 patients enrolled in a pulmonary arterial hypertension (PAH) registry showed promising treatment results in stabilising or reducing their 1-year mortality risk Continue Reading
SGLT2 inhibitors and GLP1-receptor agonists reduce CHD risk in diabetes patients: Study – Medical Dialogues
CONTEXT: Publication of an RWE study in type 2 diabetes patients treated with SGLT2 and GLP1- receptor antagonists showing a long term reduction in risk of coronary heart disease | Continue Reading
Real-world evidence solution market is projected to reach the valuation of USD 3321.7 Million by 2026 with a CAGR of 16.5% – KSU | The Sentinel Newspaper – KSU | The Sentinel Newspaper
CONTEXT: Market report on the still buoyant RWE market, or at least the valuations of the market are buoyant | Different day, different figure IMPACT: Low READ TIME: 1 min Continue Reading